Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers

Journal of Dairy Research

Volumn 70, Issue 2, 2003, Pages 165-173

  Schultz, Michael ^a   Linde, Hans Jörg ^a   Lehn, Norbert ^a   Zimmermann, Kurt ^b   Grossmann, Johannes ^a   Falk, Werner ^a   Schölmerich, Jürgen ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Institute of Microecology   (Germany)

Author keywords

Human; Immune system; Intestinal microflora; Lactobacilli; Lactobacillus GG; Probiotic therapy

Indexed keywords

ADULT; BACTEROIDES FRAGILIS; CD4-POSITIVE T-LYMPHOCYTES; CULTURE MEDIA, CONDITIONED; ESCHERICHIA COLI; FECES; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-4; INTERLEUKIN-6; INTESTINES; LACTOBACILLUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; PROBIOTICS; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); BACTEROIDES; BACTEROIDES FRAGILIS; ESCHERICHIA COLI; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS;

EID: 0037843521     PISSN: 00220299     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0022029903006034     Document Type: Article

References (65)

1. Bogdan C 2000 The function of type I interferons in antimicrobial immunity. Current Opinion In Immunology 12 419-424
2. Cong Y, Brandwein SL, McCabe RP, Lazenby A, Birkenmeier EH, Sundberg IP & Elson CO 1998 CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. Journal of Experimental Medicine 187 855-864
3. Christensen HR, Frokiaer H & Pestka JJ 2002 Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. Journal of Immunology 168 171-180
4. Cunningham-Rundles S, Ahrne S, Bengmark S, Johann-Liang R, Marshall F, Metakis L, Califano C, Dunn AM, Grassey C, Hinds G & Cervia J 2000 Probiotics and immune response. American Journal of Gastroenterology 95 S22-S25
5. De Waal-Malefyt R 1992 Interleukin 10. Current Opinion In Immunology 4 314-320
6. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K & Meyer zum Büschenfelde KH 1995 Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clinical and Experimental Immunology 102 448-455
7. Duchmann R, Schmitt E, Knolle P, Meyer zum Büschenfelde KH & Neurath MF 1996a Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. European Journal of Immunology 26 934-938
8. Duchmann R, Märker-Hermann E & Meyer zum Büschenfelde KH 1996b Bacteria-specific T-cell clones are selective in their reactivity towards different enterobacteria or H. pylori and increased in inflammatory bowel disease. Scandinavian Journal of Immunology 44 71-79
9. Duchmann R, Neurath MF & Meyer zum Büschenfelde KH 1997 Responses to self and non-self intestinal microflora in health and inflammatory bowel disease. Research in Immunology 148 589-594
10. Dugas B, Mercenier A, Lenoir-Wijnkoop I, Arnaud C, Dugas N & Postaire E 1999 Immunity and Probiotics. Immunology Today 20 9
11. Erickson KL & Hubbard NE 2000 Probiotic immunomodulation in health and disease. Journal of Nutrition 130 403S-409S
12. Fiocchi C 1998 Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115 182-205
13. Fuss IJ, Neurath M, Boirivant M, Klein JS, La Motte DE, Strong SA, Fiocchi C & Strober W 1996 Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. Journal of Immunology 157 1261-1270
14. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, Poggioli G, Miglioli M & Campieri M 2000 Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119 305-309
15. Gorbach SL, Chang TW & Goldin BR 1987 Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 26 1519
16. Gorbach SL 1999 Antibiotics and Clostridium difficile. New England Journal of Medicine 341 1690-1691
17. Groux H 2001 An overview of regulatory T cells. Microbes and Infection 3 883-889
18. Guandalini S, Pensabene L, Zikri MA, Dias JA, Casali LG, Hoekstra H, Kolacek S, Massar K, Micetic-Turk D, Papadopoulou A, De Sousa JS, Sandhu B, Szajewska H & Weizman Z 2000 Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea; a multicenter european trial. Journal of Pediatric Gastroenterology and Nutrition 30 54-60
19. Ha CL, Lee JH, Zhou HR, Ustunol Z & Pestka JJ 1999 Effects of yogurt ingestion on mucosal and systemic cytokine gene expression in the mouse. Journal of Food Protection 62 181-188
20. Hartung T, Sauer A & Wendel A 1996 Testing of immunomodulating properties in vitro. Developments In Biological Standardization 86 85-96
21. Hartung T, Von Aulock S, Freitag M, Höxtermann S, Stücker M, Hoffmann K, Altmeyer P, Kottke A & Wendel A 2000 Blood cytokine response of low-dose molgramostim (rhGM-CSF)-treated patients. Cytokine 12 1570-1574
22. Hilton E, Kolakowski P, Smith M & Singer C 1997 Efficacy of Lactobacillus GG as a diarrheal preventative in travelers. Journal of Travel Medicine 4 41-43
23. Hirano T 1998 Interleukin 6 and its receptor: ten years later. International Review of Immunology 16 249-284
24. Howard M & O'Garra A 1992 Biological properties of interleukin 10. Immunology Today 13 198-200
25. Husby S 2000 Normal immune responses to ingested foods. Journal of Pediatric Gastroenterology and Nutrition 30 S13-S19
26. Isolauri E, Majamaa H, Arvola T, Rantala I, Virtanen E & Arvilommi H 1993 Lactobacillus casei strain GG reverses increased permeability induced by cow milk in suckling rats. Gastroenterology 105 1643-1650
27. Isolauri E 2000 The use of probiotics in paediatrics. Hospital Medicine 61 6-7
28. Kohashi O, Kuwata J, Umehara K, Uemura F, Takahashi T & Ozawa A 1979 Susceptibility to adjuvant-induced arthritis among germfree, specific-pathogen-free, and conventional rats. Infection and Immunity 26 791-794
29. Kraehenbuhl J-P & Neutra MR 2000 Epithelial M cells: Differentiation and function. Annual Review of Cell Development and Biology 16 301-332
30. MacDermott RP 1996 Alterations of the mucosal immune system in inflammatory bowel disease. Journal of Gastroenterology 31 907-916
31. Mack DR, Michail S, Wei S, McDougall L & Hollingsworth MA 1999. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. American Journal of Physiology 276 G941-G950
32. Madsen KL, Doyle JS, Jewell LD, Taverini MM & Fedorak RN 1999 Lactobacillus species prevents colitis in Interleukin-10 gene-deficient mice. Gastroenterology 116 1107-1114
33. Marin ME, Tejada-Simon MV, Lee JH, Murtha J, Ustunol Z & Pestka JJ 1998 Stimulation of cytokine production in clonal macrophage and T-cell models by Steptococcus thermophilus: Comparison with Bifidobacterium sp. and Lactobacillus bulgaricus. Journal of Food Protection 61 859-864
34. Metchnikoff E 1907 The prolongation of life. In The Nature of Man, a Study in Optimistic Philosophy, pp. 161-183 (Ed. E Chalmers). London: Heinemann
35. Miettinen M, Vuopio-Varkila J & Varkila K 1996 Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infection and Immunity 64 5403-5405
36. Miettinen M, Matikainen S, Vuopio-Varkila J, Pirhonen J, Varkila K, Kurimoto M & Julkunen I 1998 Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infection and Immunity 66 6058-6062
37. Miettinen M, Lehtonen A, Julkunen I & Matikainen S 2000 Lactobacilli and Streptococci activate NF-kappa B and STAT signaling pathways in human macrophages. Journal of Immunology 164 3733-3740
38. Neish AS, Gewirtz AT, Zeng H, Young AF, Hobert ME, Karmali V, Rao AS & Madara JL 2000 Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination. Science 289 1560-1563
39. Nicaise P, Gleizes A, Forestier F, Quero AM & Labarre C 1993 Influence of intestinal bacterial flora on cytokine (IL-1, IL-6 and TNF-alpha) production by mouse peritoneal macrophages. European Cytokine Network 4 133-138
40. Nicaise P, Gleizes A, Sandre C, Kergot R, Lebrec H, Forestier F & Labarre C 1999 The intestinal microflora regulates cytokine production positively in spleen-derived macrophages but negatively in bone marrow-derived macrophages. European Cytokine Network 10 365-372
41. Oksanen P, Salminen S, Saxelin M, Hämäläinen P, Ihantola-Vormisto A, Muurasniemi-Isoviita L, Nikkari S, Oksanen T, Pörsti I, Salminen E, Siitonen S, Stuckey H, Toppila A & Vapaatalo H 1990 Prevention of traveler's diarrhea by Lactobacillus GG. Annals of Medicine 22 53-56
42. Onderdonk AB, Franklin ML & Cisneros RL 1981 Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora. Infection and Immunity 32 225-231
43. Owen-Schaub LB, DeMars M, Murphy EC & Grimm EA 1991 IL-2 dose regulates TNF-alpha mRNA transcription and protein secretion in human peripheral blood lymphocytes. Cellular Immunology 132 193-200
44. Paton AW 1998 Detection and characterization of shiga toxigenic Escherichia coli by using multiplex PCR assay for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfbO111 and rfbO157. Journal of Clinical Microbiology 36 598-602
45. Powrie F 1995 T cells in inflammatory bowel disease. Protective and pathogenic roles. Immunity 3 171-175
46. Probert CS, Chott A, Turner JA, Saubermann LJ, Stevens AC, Bodinaku K, Elson CO, Balk SP & Blumberg RS 1996 Persistent clonal expansion of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease. Journal of Immunology 157 3183-3191
47. Rath HC, Sellon RK & Sartor RB 1996a Microbial factors in chronic intestinal inflammation. Current Opinion in Gastroenterology 12 327-333
48. Rath HC, Schultz M, Freitag R, Dieleman LA, Li F, Linde HI, Schölmerich J & Sartor RB 2001 Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infection and Immunity 69 2277-2285
49. Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE, Balish E, Taurog JD, Hammer RE, Wilson KH & Sartor RB 1996 Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. Journal of Clinical Investigation 98 945-953
50. Rothkotter HJ, Pabst R & Bailey M 1999 Lymphocyte migration in the intestinal mucosa: entry, transit and emigration of lymphoid cells and the influence of antigen. Veterinary Immunology and Immunopathology 72 157-165
51. Schreiber S, MacDermott RP, Raedler A, Pinnau R, Bertovich MJ & Nash GS 1991 Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenteology 101 1020-1030
52. Schultz M, Veltkamp C, Dielemann LA, Wyrick RB, Tonkongy SL & Sartor RB 2002 Lactobacillus plantarum 299v in treatment and prevention of spontaneous colitis in IL-10-deficient mice. Inflammatory Bowel Disease 8 71-80
53. Schultz M & Sartor RB 1997a The contribution of bacterial flora to chronic intestinal inflammation. In Inflammatory Bowel Disease, pp. 17-24 (Ed. R Caprilli). Stuttgart: Schattauer Verlagsgesellschaft
54. Schultz M & Sartor RB 1997b Aberrant host immune responses to luminal bacteria in the pathogenesis of chronic inflammatory bowel disease. In The immunobiology of H. pylori: From pathogenesis to prevention, pp. 167-182 (Eds PB Ernst, P Michetti & KA Smith). Philadelphia: Lippincott-Raven
55. Shanahan F 2000 Probiotics and inflammatory bowel disease: is there a scientific rationale? Inflammatory Bowel Disease 6 107-115
56. Sottong PR, Rosebrock JA, Britz JA & Kramer TR 2000 Measurement of T-lymphocyte responses in whole-blood cultures using newly synthesized DNA and ATP. Clinical Diagnostics and Laboratory Immunology 7 307-311
57. Tannock GW, Munro K, Harmsen HJ, Welling GW, Smart J & Gopal PK 2000 Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Applied and Environmental Microbiology 66 2578-2588
58. Tejada-Simon MV, Ustunol Z & Pestka JJ 1999a Ex vivo effects of Lactobacilli, Streptococci, and Bifidobacteria ingestion on cytokine and nitric oxide production in a murine model. Journal of Food Production 62 162-169
59. Tejada-Simon MV, Ustunol Z & Pestka JJ 1999b Effects of lactic acid bacteria ingestion on basal cytokine mRNA and immunoglobulin levels in the mouse. Journal of Food Protection 52 287-291
60. Ulisse S, Gionchetti P, D'Alo SD, Russo FP, Pesce I, Ricci G, Rizzello F, Helwig U, Cifone MG, Campieri M & De Simone C 2001 Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinase in pouchitis: effects of probiotic treatment. American Journal of Gastroenterology 96 2691-2699
61. Van Deventer SJ 2000 Immunotherapy of Crohn's disease. Scandinavian Journal of Immunology 51 18-22
62. Vanderhoof JA 2000 Probiotics and intestinal inflammatory disorders in infants and children. Journal of Pediatric Gastroenterology and Nutrition 30 S34-S38
63. Venturi A, Gionchetti P, Rizzello F, Johansson R, Zucconi E, Brigidi P, Matteuzzi D & Campieri M 1999 Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Alimentary Pharmacology and Therapeutics 13 1103-1108
64. Wahl SM, Hunt DA, Allen JB, Wilder RL, Paglia L & Hand AR 1986 Bacterial cell wall-induced hepatic granulomas. An in vivo model of T cell-dependent fibrosis. Journal of Experimental Medicine 163 884-902
65. White AG, Raju KT, Keddie S & Abouna GM 1989 Lymphocyte activation: changes in intracellular adenosine triphosphate and deoxyribonucleic acid synthesis. Immunology Letters 22 47-50